Publicaciones en las que colabora con Jordi A. Matías-Guiu (57)

2024

  1. Murine experimental models of amyotrophic lateral sclerosis: An update

    Neurologia, Vol. 39, Núm. 3, pp. 282-291

2022

  1. Cell therapy as a treatment strategy in amyotrophic lateral sclerosis

    Neurology Perspectives, Vol. 2, pp. S69-S73

  2. Chitosan-Hydroxycinnamic Acids Conjugates: Emerging Biomaterials with Rising Applications in Biomedicine

    International journal of molecular sciences, Vol. 23, Núm. 20

  3. Diagnosis of Alzheimer's disease and behavioural variant frontotemporal dementia with machine learning-aided neuropsychological assessment using feature engineering and genetic algorithms

    International Journal of Geriatric Psychiatry, Vol. 37, Núm. 2

  4. Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome

    Brain Sciences, Vol. 12, Núm. 2

  5. Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis

    Life, Vol. 12, Núm. 9

  6. Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 20

  7. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms

    Medical and Biological Engineering and Computing, Vol. 60, Núm. 9, pp. 2737-2756

  8. Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging

    Frontiers in Aging Neuroscience, Vol. 13

  9. Identification of the main components of spontaneous speech in primary progressive aphasia and their neural underpinnings using multimodal MRI and FDG-PET imaging

    Cortex, Vol. 146, pp. 141-160

  10. Neural basis of visuospatial tests in behavioral variant frontotemporal dementia

    Frontiers in Aging Neuroscience, Vol. 14

  11. Neuropsychological Predictors of Fatigue in Post-COVID Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  12. Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 823-840

  13. Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders

    Cells, Vol. 11, Núm. 19

  14. Persistent olfactory dysfunction after COVID-19 is associated with reduced perfusion in the frontal lobe

    Acta Neurologica Scandinavica

  15. The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination

    Life, Vol. 12, Núm. 4

  16. Validation of a brief cross-cultural cognitive screening test in Multiple Sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 67

  17. Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F

    Multiple Sclerosis and Related Disorders, Vol. 63

2021

  1. Application of machine learning to electroencephalography for the diagnosis of primary progressive aphasia: A pilot study

    Brain Sciences, Vol. 11, Núm. 10

  2. Intranasal administration of undifferentiated oligodendrocyte lineage cells as a potential approach to deliver oligodendrocyte precursor cells into brain

    International Journal of Molecular Sciences, Vol. 22, Núm. 19